Cytori Therapeutics (CYTX) CFO Mark E Saad buys 10,000 Shares
CFO of Cytori Therapeutics Inc (CYTX) Mark E Saad buys 10,000 shares
of CYTX on 03/14/2012 at an average price of $2.55 a share.
The Bottom Line: He now has purchased and owns 152,500 shares, all coming from the … open market (no option exercises or restricted stock grants …Most of the purchases were at prices well north of the purchase reported on 3/14/12. Among all stem cell company C-level execs, Mark has probably made the largest personal investment out of the open market.
Related Posts
Categories: Cytori Therapeutics, CYTX
